Oryzon Genomics S.A. (BME:ORY)
2.610
-0.035 (-1.32%)
Aug 1, 2025, 5:35 PM CET
Oryzon Genomics Employees
Oryzon Genomics had 47 employees as of December 31, 2024. The number of employees increased by 1 or 2.17% compared to the previous year.
Employees
47
Change (1Y)
1
Growth (1Y)
2.17%
Revenue / Employee
$158,959
Profits / Employee
-$89,785
Market Cap
202.31M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 47 | 1 | 2.17% |
Dec 31, 2023 | 46 | 2 | 4.78% |
Dec 31, 2022 | 44 | 0 | - |
Dec 31, 2021 | 44 | 1 | 1.15% |
Dec 31, 2020 | 43 | 3 | 8.50% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Grifols | 23,833 |
Laboratorios Farmaceuticos Rovi | 2,197 |
Almirall | 2,026 |
Pharma Mar | 500 |
Faes Farma | 1,775 |
Clínica Baviera | 1,759 |
Laboratorio Reig Jofre | 1,331 |
Atrys Health | 2,045 |
Oryzon Genomics News
- 2 months ago - Oryzon Genomics S.A. GAAP EPS of -$0.03 - Seeking Alpha
- 5 months ago - Oryzon Genomics S.A. GAAP EPS of -$0.02 - Seeking Alpha
- 6 months ago - ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders' Meeting - Benzinga